文献
J-GLOBAL ID:202202261357963666
整理番号:22A0911233
COVID-19ワクチンと血液学的異常のリスク: コホート内症例対照研究と自己管理症例シリーズ研究【JST・京大機械翻訳】
COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study
著者 (29件):
Sing Chor-Wing
(Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Sing Chor-Wing
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Tang Casey Tze Lam
(Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Chui Celine Sze Ling
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Chui Celine Sze Ling
(School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Chui Celine Sze Ling
(School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Fan Min
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Lai Francisco Tsz Tsun
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Lai Francisco Tsz Tsun
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Li Xue
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Li Xue
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Li Xue
(Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Wan Eric Yuk Fai
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Wan Eric Yuk Fai
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Wan Eric Yuk Fai
(Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Wong Carlos King Ho
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Wong Carlos King Ho
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Wong Carlos King Ho
(Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Chan Esther Wai Yin
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Chan Esther Wai Yin
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Hung Ivan Fan Ngai
(Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Hung Ivan Fan Ngai
(Expert Committee on Clinical Events Assessment Following COVID-19 Immunization, Department of Health, The Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China)
,
Leung Anskar Yu-Hung
(Division of Haematology, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Cheung Ching-Lung
(Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Cheung Ching-Lung
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Wong Ian Chi Kei
(Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Special Administrative Region, China)
,
Wong Ian Chi Kei
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China)
,
Wong Ian Chi Kei
(Expert Committee on Clinical Events Assessment Following COVID-19 Immunization, Department of Health, The Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China)
,
Wong Ian Chi Kei
(Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK)
資料名:
American Journal of Hematology
(American Journal of Hematology)
巻:
97
号:
4
ページ:
470-480
発行年:
2022年
JST資料番号:
E0721B
ISSN:
0361-8609
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)